First mRNA Flu Vaccine Approved for Older Adults as Flu Season Nears

The FDA has approved the first-ever mRNA-based flu vaccine for adults 50 and older, a potential game-changer for the upcoming respiratory virus season. Made by Moderna and called mFLUSIVA, this vaccine uses the same revolutionary mRNA technology that powered the COVID-19 shots.

Plain English

Think of this as a flu shot 2.0. Instead of the traditional method of growing viruses in chicken eggs, this vaccine uses messenger RNA to teach your body how to fight off the flu...